Please use this identifier to cite or link to this item:
http://localhost:80/xmlui/handle/123456789/13846
Title: | Curative effect of kangfuyan capsule combined with antibiotic treatment on pelvic inflammatory disease |
Authors: | Wang, Lu Chen, Yi Ouyang, Yin-Luan Wang, Feng-Wei Zhang, Run-Ju Chen, Xiao |
Keywords: | Kangfuyan capsule Pelvic inflammatory disease damp-heat and blood stasis type Curative effect |
Issue Date: | 15-Nov-2021 |
Publisher: | Karachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi. |
Citation: | Ting, L., Li-Ying, W. U., Xiao-Mei, Y., Yao, C., Xue-Jiao, D. U., Xue-Dan, L., ... & Wen-Ting, Z. (2021). Curative effect of kangfuyan capsule combined with antibiotic treatment on pelvic inflammatory disease. Pakistan Journal of Pharmaceutical Sciences, 34(6 (Special)), 2479-2485. |
Abstract: | This study aims to investigate the curative effect of Kangfuyan capsule in the treatment of damp-heat and blood stasis type of pelvic inflammatory disease (PID), and its influence on serum inflammatory factors IL-6, CRP and TNF-α. A total of 83 patients with PID were randomly divided into two groups: Western medicine group (control group, n=41) received oral antibiotics (azithromycin + metronidazole) alone and the traditional Chinese medicine combined with Western medicine group (experimental group, n=42) received Kangfuyan capsule based on Western medicine therapy. Clinical efficacy between these two groups and the influence of drugs in serum inflammatory factors (IL-6, CRP and TNF-α) were compared. The total effective rate was 78.05% in the control group and 97.62% in the experimental group and difference between these two groups was statistically significant (P<0.01). The symptoms and signs in the two groups significantly improved after treatment (P<0.05) and improvement rate was significantly better in the experimental group than in the control group (P<0.05). After treatment, serum inflammatory factor levels in the two groups were significantly lower than levels before treatment (P<0.05) and improvement rate was significantly better in the experimental group than in the control group (P<0.05). Kangfuyan capsule combined with antibiotics can effectively relieve the symptoms and signs of patients, improve the efficiency of treatment, provide high safety, and does not increase adverse reactions. |
URI: | http://142.54.178.187:9060/xmlui/handle/123456789/13846 |
ISSN: | 1011-601X |
Appears in Collections: | Issue 6 (Special) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
15-9396-SP.htm | 141 B | HTML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.